Goldman Sachs Group Inc Maxcyte, Inc. Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Maxcyte, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 286,828 shares of MXCT stock, worth $682,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
286,828
Previous 286,828 -0.0%
Holding current value
$682,650
Previous $783,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$2.73 - $5.1 $633,933 - $1.18 Million
-232,210 Reduced 44.74%
286,828 $783,000
Q4 2024

Feb 11, 2025
BUY
$3.23 - $4.43 $44,089 - $60,469
13,650 Added 2.7%
519,038 $2.16 Million
Q3 2024

Nov 14, 2024
BUY
$3.68 - $5.06 $579,728 - $797,127
157,535 Added 45.29%
505,388 $1.97 Million
Q2 2024

Aug 13, 2024
BUY
$3.63 - $5.0 $591,668 - $814,970
162,994 Added 88.17%
347,853 $1.36 Million
Q1 2024

May 15, 2024
SELL
$3.94 - $5.38 $49,521 - $67,621
-12,569 Reduced 6.37%
184,859 $774,000
Q4 2023

Feb 13, 2024
BUY
$2.6 - $5.24 $37,419 - $75,414
14,392 Added 7.86%
197,428 $927,000
Q3 2023

May 14, 2024
SELL
$3.02 - $5.1 $43,463 - $73,399
-14,392 Reduced 7.29%
183,036 $571,000
Q3 2023

Nov 14, 2023
BUY
$3.02 - $5.1 $53,360 - $90,111
17,669 Added 10.68%
183,036 $571,000
Q2 2023

May 14, 2024
BUY
$3.69 - $5.35 $111,242 - $161,286
30,147 Added 22.29%
165,367 $759,000
Q2 2023

Aug 14, 2023
BUY
$3.69 - $5.35 $111,242 - $161,286
30,147 Added 22.29%
165,367 $759,000
Q1 2023

May 14, 2024
BUY
$4.03 - $5.89 $49,488 - $72,329
12,280 Added 9.99%
135,220 $669,000
Q1 2023

May 11, 2023
BUY
$4.03 - $5.89 $49,488 - $72,329
12,280 Added 9.99%
135,220 $669,000
Q4 2022

May 14, 2024
SELL
$4.92 - $7.4 $1.65 Million - $2.48 Million
-335,480 Reduced 73.18%
122,940 $671,000
Q4 2022

Feb 13, 2023
SELL
$4.92 - $7.4 $1.65 Million - $2.48 Million
-335,480 Reduced 73.18%
122,940 $671,000
Q3 2022

May 14, 2024
SELL
$4.52 - $6.51 $3.77 Million - $5.43 Million
-833,822 Reduced 64.53%
458,420 $2.98 Million
Q3 2022

Nov 10, 2022
SELL
$4.52 - $6.51 $3.77 Million - $5.43 Million
-833,822 Reduced 64.53%
458,420 $2.98 Million
Q2 2022

May 14, 2024
BUY
$3.59 - $6.81 $3.93 Million - $7.46 Million
1,094,814 Added 554.54%
1,292,242 $6.11 Million
Q2 2022

Aug 15, 2022
BUY
$3.59 - $6.81 $1.04 Million - $1.96 Million
288,504 Added 28.74%
1,292,242 $6.11 Million
Q1 2022

May 16, 2022
BUY
$5.26 - $10.84 $4.02 Million - $8.27 Million
763,344 Added 317.54%
1,003,738 $7.02 Million
Q4 2021

Feb 14, 2022
BUY
$8.87 - $12.94 $745,177 - $1.09 Million
84,011 Added 53.72%
240,394 $2.45 Million
Q3 2021

Nov 10, 2021
BUY
$12.21 - $17.2 $1.91 Million - $2.69 Million
156,383 New
156,383 $1.91 Million

Others Institutions Holding MXCT

# of Institutions
119
Shares Held
73.2M
Call Options Held
0
Put Options Held
0
View Full List

About MAXCYTE, INC.

MXCT Quotes by TradingView
  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $242M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email